Li YY - Search Results

1

MicroRNA-33a-mediated downregulation of Pim-3 kinase expression renders human pancreatic cancer cells sensitivity to gemcitabine.

Liang C, Yu XJ, Guo XZ, Sun MH, Wang Z, Song Y, Ni QX, Li HY, Mukaida N, Li YY. Liang C, et al. Among authors: li yy, li hy. Oncotarget. 2015 Jun 10;6(16):14440-55. doi: 10.18632/oncotarget.3885. Oncotarget. 2015. PMID: 25971209 Free PMC article.

2

Essential contribution of Ets-1 to constitutive Pim-3 expression in human pancreatic cancer cells.

Li YY, Wu Y, Tsuneyama K, Baba T, Mukaida N. Li YY, et al. Cancer Sci. 2009 Mar;100(3):396-404. doi: 10.1111/j.1349-7006.2008.01059.x. Epub 2008 Dec 16. Cancer Sci. 2009. PMID: 19154409 Free article.

3

Roles of Pim-3, a novel survival kinase, in tumorigenesis.

Mukaida N, Wang YY, Li YY. Mukaida N, et al. Among authors: li yy. Cancer Sci. 2011 Aug;102(8):1437-42. doi: 10.1111/j.1349-7006.2011.01966.x. Epub 2011 May 23. Cancer Sci. 2011. PMID: 21518143 Free article. Review.

4

A novel regulatory mechanism of Pim-3 kinase stability and its involvement in pancreatic cancer progression.

Zhang F, Liu B, Wang Z, Yu XJ, Ni QX, Yang WT, Mukaida N, Li YY. Zhang F, et al. Among authors: li yy. Mol Cancer Res. 2013 Dec;11(12):1508-20. doi: 10.1158/1541-7786.MCR-13-0389. Epub 2013 Oct 28. Mol Cancer Res. 2013. PMID: 24165482

5

Use of regulators and inhibitors of Pim-1, a serine/threonine kinase, for tumour therapy (review).

Liang C, Li YY. Liang C, et al. Among authors: li yy. Mol Med Rep. 2014 Jun;9(6):2051-60. doi: 10.3892/mmr.2014.2139. Epub 2014 Apr 11. Mol Med Rep. 2014. PMID: 24737044 Review.

6

Pim-3 promotes human pancreatic cancer growth by regulating tumor vasculogenesis.

Liu B, Wang Z, Li HY, Zhang B, Ping B, Li YY. Liu B, et al. Among authors: li yy, li hy. Oncol Rep. 2014 Jun;31(6):2625-34. doi: 10.3892/or.2014.3158. Epub 2014 Apr 25. Oncol Rep. 2014. PMID: 24789328

7

Pathophysiological roles of Pim-3 kinase in pancreatic cancer development and progression.

Li YY, Mukaida N. Li YY, et al. World J Gastroenterol. 2014 Jul 28;20(28):9392-404. doi: 10.3748/wjg.v20.i28.9392. World J Gastroenterol. 2014. PMID: 25071334 Free PMC article. Review.

8

Pancreatic cancer: diagnosis and treatments.

Li HY, Cui ZM, Chen J, Guo XZ, Li YY. Li HY, et al. Among authors: li yy. Tumour Biol. 2015 Mar;36(3):1375-84. doi: 10.1007/s13277-015-3223-7. Epub 2015 Feb 14. Tumour Biol. 2015. PMID: 25680410 Review.

9

miR-33a suppresses the nuclear translocation of β-catenin to enhance gemcitabine sensitivity in human pancreatic cancer cells.

Liang C, Wang Z, Li YY, Yu BH, Zhang F, Li HY. Liang C, et al. Among authors: li yy, li hy. Tumour Biol. 2015 Dec;36(12):9395-403. doi: 10.1007/s13277-015-3679-5. Epub 2015 Jun 26. Tumour Biol. 2015. PMID: 26113407

10

Natural compound Oblongifolin C confers gemcitabine resistance in pancreatic cancer by downregulating Src/MAPK/ERK pathways.

Li Y, Xi Z, Chen X, Cai S, Liang C, Wang Z, Li Y, Tan H, Lao Y, Xu H. Li Y, et al. Cell Death Dis. 2018 May 1;9(5):538. doi: 10.1038/s41419-018-0574-1. Cell Death Dis. 2018. PMID: 29749405 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,464 results

Search Page